Simpson E, Kircik L, Blauvelt A, Kuligowski M, Venturanza M, Sun K, Eichenfeld L. Long-Term Safety and Disease Control With Ruxolitinib Cream in Patients With More Severe Atopic Dermatitis: Pooled Results From Two Phase 3 Studies. J of Skin [Internet]. 2021 Nov. 5 [cited 2024 Jul. 3];5(6):s66. Available from: https://jofskin.org/33014/index.php/skin/article/view/1417